Cabot (FRA:CBT) Total Liabilities: €1,912 Mil (As of Mar. 2026)

What is Cabot Total Liabilities?

Cabot FRA:CBT -1.39% 74 Total Liabilities is €1,912 Mil as of Mar. 2026. GuruFocus rates FRA:CBT with a GF Score™ of 74/100 and a GF Value™ of €65.26 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Cabot's Total Liabilities for the quarter that ended in Mar. 2026 was €1,912 Mil.

Cabot's quarterly Total Liabilities declined from Sep. 2025 (€1,797.72 Mil) to Dec. 2025 (€1,731.91 Mil) but then increased from Dec. 2025 (€1,731.91 Mil) to Mar. 2026 (€1,911.65 Mil).

Cabot's annual Total Liabilities declined from Sep. 2023 (€2,058.59 Mil) to Sep. 2024 (€1,933.55 Mil) and declined from Sep. 2024 (€1,933.55 Mil) to Sep. 2025 (€1,797.72 Mil).

Cabot Total Liabilities Related Terms

Cabot Total Liabilities Historical Data

* Premium members only.

The historical data trend for Cabot's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cabot Total Liabilities Chart

Cabot Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

Total Liabilities

Get a 7-Day Free Trial

1,883.60

2,517.93

2,058.59

1,933.55

1,797.72

Cabot Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Liabilities	Get a 7-Day Free Trial															2,029.45	1,867.52	1,797.72	1,731.91	1,911.65

74GF Score

Cabot Corp FRA:CBT

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cabot Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cabot's Total Liabilities for the fiscal year that ended in Sep. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	815.364	+	(801.732	+	105.648
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	33.228	+	41.748	+	0)
	=	1,798

Total Liabilities	=	Total Assets (A: Sep. 2025 )	-	Total Equity (A: Sep. 2025 )
	=	3250.38	-	1452.66
	=	1,798

Cabot's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	923.82	+	(746.495	+	206.735
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	34.6	+	0	+	0)
	=	1,912

Total Liabilities	=	Total Assets (Q: Mar. 2026 )	-	Total Equity (Q: Mar. 2026 )
	=	3370.905	-	1459.255
	=	1,912

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of €1,912 Mil mean?

Cabot (FRA:CBT) has a Total Liabilities of €1,912 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cabot and its competitors.

Is Cabot's Total Liabilities too high?

Cabot's current Total Liabilities is €1,912 Mil. Overall, Cabot has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Cabot's Total Liabilities compare to SXT and BCPC?

Cabot's Total Liabilities of €1,912 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Chemicals company?

A good Total Liabilities depends on the Chemicals industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cabot and its competitors. Cabot's current Total Liabilities is €1,912 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cabot stock overvalued right now?

Based on GuruFocus' analysis, Cabot (FRA:CBT) is currently considered Modestly Overvalued. The stock's GF Value™ is €65.26, compared to a current price of €74.35 — trading 13.9% above its estimated fair value. The current Total Liabilities is €1,912 Mil. Cabot's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Cabot (FRA:CBT), the current Total Liabilities is €1,912 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cabot (FRA:CBT) Overvalued in 2026?

Based on GuruFocus' analysis, Cabot stock appears to be overvalued. The current stock price of €74.35 is trading 13.9% above its estimated GF Value™ of €65.26. GuruFocus considers Cabot to be Modestly Overvalued.

Key valuation signals for FRA:CBT:

Total Liabilities: €1,912 Mil
GF Value™: €65.26 vs. price of €74.35 (13.9% above fair value)
GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the FRA:CBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cabot Business Description

Industry Basic Materials Chemicals

Comparable Companies SXT BCPC PRM AVNT FUL HWKN WDFC CC CLMT ASH LIN XPAR:AI SHW ECL APD SHSE:603256 XSWX:GIVN TPE:1303 XSWX:SIKA SHSE:600309

Other Exchanges CBT:USA CBT:Germany

Address Two Seaport Lane, Suite 1400, Boston, MA, USA, 02210

Website https://www.cabotcorp.com

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

74GF Score

Get the complete analysis for FRA:CBT

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€74.35

Price

€65.26

GF Value

View FRA:CBT Analysis

See Total Liabilities data for all stocks →